Broglio, Kristine
AstraZeneca,
United States
2024 Rank: 104622
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 4063 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104622 | 114710 |
| Total Cites | 15031 | 16691 |
| H-index | 55 | 58 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 140 | 140 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 823 | 857 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 907 | 955 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13726 | 15026 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
9.95%
|
|
Broglio, Kristine
Berry Consultants,
United States
2023 Rank: 114009
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Statistics & Probability
Rank in SubField 1: 4446 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114009 | 125077 |
| Total Cites | 14090 | 15691 |
| H-index | 54 | 57 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 97 | 97 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 710 | 743 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 783 | 830 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12841 | 14088 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
10.20%
|
|
Broglio, Kristine
AstraZeneca,
United States
2022 Rank: 126854
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Statistics & Probability
Rank in SubField 1: 4862 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126854 | 140074 |
| Total Cites | 12929 | 14473 |
| H-index | 53 | 55 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 59 | 59 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 594 | 624 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 650 | 693 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11761 | 12973 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
10.67%
|
|
Broglio, Kristine
AstraZeneca,
United States
2021 Rank: 131293
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 5044 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131293 | 144136 |
| Total Cites | 12325 | 13789 |
| H-index | 51 | 53 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 554 | 583 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 605 | 646 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11210 | 12356 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
10.62%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.